DANIELLE MICHELLE MITCHELL, LMP
Massage Therapy at 70 St, Seattle, WA
License number
Washington MA60416417
Category
Restorative Service Providers
Type
Massage Therapist
Address
Address
2
460 EAST 70Th St, Seattle, WA 98115
7621 67Th St NE, Marysville, WA 98270
7621 67Th St NE, Marysville, WA 98270
Phone
(206) 522-4000
(206) 522-4003 (Fax)
(360) 618-3314
(206) 522-4003 (Fax)
(360) 618-3314
Personal information
See more information about DANIELLE MICHELLE MITCHELL at radaris.comName
Address
Phone
4401 Bay Vista Blvd, Bremerton, WA 98312
3194 Old Olympic Hwy, Port Angeles, WA 98362
8398 Grouse Cresent Dr, Blaine, WA 98230
25413 36Th Ave E, Spanaway, WA 98387
3194 Old Olympic Hwy, Port Angeles, WA 98362
Professional information
Research Associate At Alder Biopharmaceuticals
Position:
Senior Research Associate at Alder Biopharmaceuticals
Location:
Greater Seattle Area
Industry:
Biotechnology
Work:
Alder Biopharmaceuticals
since Mar 2008
-
Senior Research Associate
University of Washington
Jan 2007 - Mar 2008
-
Research Scientist/Engineer II
Education:
University of Washington 2003 - 2006
MS, Fisheries (Population Genetics) California State University-Long Beach 1997 - 2001
B.S., Biology (Zoology), Marine Biology
MS, Fisheries (Population Genetics) California State University-Long Beach 1997 - 2001
B.S., Biology (Zoology), Marine Biology
Danielle Mitchell - Tukwila, WA
Work:
Lane Bryant
Part Time Sales Leader Reischling Press Inc - Tukwila, WA
Quality Assurance Inspector; picker; shiper Park Shore - Seattle, WA
Server
Part Time Sales Leader Reischling Press Inc - Tukwila, WA
Quality Assurance Inspector; picker; shiper Park Shore - Seattle, WA
Server
Education:
Cornish College of the Arts - Seattle, WA
BFA in Theater Evergreen High School - Seattle, WA
High School Diploma
BFA in Theater Evergreen High School - Seattle, WA
High School Diploma
Multi-Copy Strategy For High-Titer And High-Purity Production Of Multi-Subunit Proteins Such As Antibodies In Transformed Microbes Such As Pichia Pastoris
US Patent:
2013004, Feb 21, 2013
Filed:
Aug 20, 2012
Appl. No.:
13/589584
Inventors:
Danielle Marie Mitchell - Seattle WA, US
Leon F. Garcia-Martinez - Woodinville WA, US
Patricia Dianne McNeill - Federal Way WA, US
Ethan Wayne Ojala - Snohomish WA, US
Mehmet Inan - Antalya, TR
John Latham - Seattle WA, US
Leon F. Garcia-Martinez - Woodinville WA, US
Patricia Dianne McNeill - Federal Way WA, US
Ethan Wayne Ojala - Snohomish WA, US
Mehmet Inan - Antalya, TR
John Latham - Seattle WA, US
International Classification:
C40B 30/04, C12P 21/00, C12N 1/19
US Classification:
506 9, 4352551, 4352555, 435 696
Abstract:
Methods for producing heterologous multi-subunit proteins in transformed cells are disclosed. In particular, the present disclosure provides improved methods of producing multi-subunit proteins, including antibodies and other multi-subunit proteins, which may or may not be secreted, with a higher yield and decreased production of undesired side-products. In exemplary embodiments, the transformed cells are a yeast, e.g., methylotrophic yeast such as
Anti-Ngf Compositions And Use Thereof
US Patent:
2013033, Dec 19, 2013
Filed:
Mar 15, 2013
Appl. No.:
13/833338
Inventors:
Benjamin H. Dutzar - Seattle WA, US
Brian R. Kovacevich - Snohomish WA, US
Patricia Dianne McNeill - Federal Way WA, US
Danielle M. Mitchell - Seattle WA, US
Ethan W. Ojala - Snohomish WA, US
Pei Fan - Bothell WA, US
Jens Billgren - Seattle WA, US
Erica A. Stewart - Shoreline WA, US
Corinne C. Akatsuka - Hilo HI, US
Betty Yu-Ching Chang - Cupertino CA, US
John A. Latham - Seattle WA, US
Leon F. Garcia-Martinez - Woodinville WA, US
Brian R. Kovacevich - Snohomish WA, US
Patricia Dianne McNeill - Federal Way WA, US
Danielle M. Mitchell - Seattle WA, US
Ethan W. Ojala - Snohomish WA, US
Pei Fan - Bothell WA, US
Jens Billgren - Seattle WA, US
Erica A. Stewart - Shoreline WA, US
Corinne C. Akatsuka - Hilo HI, US
Betty Yu-Ching Chang - Cupertino CA, US
John A. Latham - Seattle WA, US
Leon F. Garcia-Martinez - Woodinville WA, US
International Classification:
C07K 16/22
US Classification:
4241351, 5303892, 5303873, 5303913, 5303917, 536 2353, 4353201, 435335, 4352542, 4352523, 43525411, 435419, 4241581, 435 71, 435328
Abstract:
The present invention is directed to antibodies and fragments thereof having binding specificity for NGF. Another embodiment of this invention relates to the antibodies described herein, and binding fragments thereof, comprising the sequences of the V, Vand CDR polypeptides described herein, and the polynucleotides encoding them. The invention also contemplates conjugates of anti-NGF antibodies and binding fragments thereof conjugated to one or more functional or detectable moieties. The invention also contemplates methods of making said anti-NGF antibodies and binding fragments thereof. Embodiments of the invention also pertain to the use of anti-NGF antibodies, and binding fragments thereof, for the diagnosis, assessment and treatment of diseases and disorders associated with NGF.
Anti-Ngf Compositions And Use Thereof
US Patent:
2012014, Jun 14, 2012
Filed:
Dec 1, 2011
Appl. No.:
13/309295
Inventors:
Benjamin H. Dutzar - Seattle WA, US
Brian R. Kovacevich - Snohomish WA, US
Patricia Dianne NcNeill - Federal Way WA, US
Danielle M. Mitchell - Seattle WA, US
Ethan W. Ojala - Snohomish WA, US
Pei Fan - Bothell WA, US
Jens Billgren - Seattle WA, US
Erica A. Stewart - Shoreline WA, US
Corinne C. Akatsuka - Hilo HI, US
Betty Yu-Ching Chang - Cupertino CA, US
John A. Latham - Seattle WA, US
Leon F. Garcia-Martinez - Woodinville WA, US
Brian R. Kovacevich - Snohomish WA, US
Patricia Dianne NcNeill - Federal Way WA, US
Danielle M. Mitchell - Seattle WA, US
Ethan W. Ojala - Snohomish WA, US
Pei Fan - Bothell WA, US
Jens Billgren - Seattle WA, US
Erica A. Stewart - Shoreline WA, US
Corinne C. Akatsuka - Hilo HI, US
Betty Yu-Ching Chang - Cupertino CA, US
John A. Latham - Seattle WA, US
Leon F. Garcia-Martinez - Woodinville WA, US
International Classification:
A61K 39/395, C12N 15/13, A61K 49/00, A61K 51/10, A61P 29/00, A61P 25/00, A61P 19/10, A61P 35/00, A61P 1/16, A61P 25/06, A61P 31/04, A61P 21/00, C12N 15/63, C12N 5/10, C12N 1/21, C12N 1/15, C12N 1/19, C12N 9/96, C12P 21/02, A61P 37/08, C07K 16/22
US Classification:
424 149, 5303892, 5303873, 5303913, 536 2353, 4241581, 424 91, 5303917, 5303911, 4353201, 435335, 4352523, 435419, 43525411, 4352542, 43525423, 424 96, 435188, 530367, 435 696, 800 6
Abstract:
The present invention is directed to antibodies and fragments thereof having binding specificity for NGF. Another embodiment of this invention relates to the antibodies described herein, and binding fragments thereof, comprising the sequences of the V, Vand CDR polypeptides described herein, and the polynucleotides encoding them. The invention also contemplates conjugates of anti-NGF antibodies and binding fragments thereof conjugated to one or more functional or detectable moieties. The invention also contemplates methods of making said anti-NGF antibodies and binding fragments thereof. Embodiments of the invention also pertain to the use of anti-NGF antibodies, and binding fragments thereof, for the diagnosis, assessment and treatment of diseases and disorders associated with NGF.
Anti-Cgrp Compositions And Use Thereof
US Patent:
2012029, Nov 22, 2012
Filed:
May 21, 2012
Appl. No.:
13/476465
Inventors:
Brian Robert Kovacevich - Snohomish WA, US
Leon F. Garcia-Martinez - Woodinville WA, US
Katie Olson - Kenmore WA, US
Benjamin H. Dutzar - Seattle WA, US
Jens J. Billgren - Seattle WA, US
John A. Latham - Seattle WA, US
Danielle M. Mitchell - Seattle WA, US
Patricia Dianne Mcneill - Federal Way WA, US
Nicole M. Janson - Edmonds WA, US
Maria-Cristina Loomis - Bothell WA, US
Leon F. Garcia-Martinez - Woodinville WA, US
Katie Olson - Kenmore WA, US
Benjamin H. Dutzar - Seattle WA, US
Jens J. Billgren - Seattle WA, US
John A. Latham - Seattle WA, US
Danielle M. Mitchell - Seattle WA, US
Patricia Dianne Mcneill - Federal Way WA, US
Nicole M. Janson - Edmonds WA, US
Maria-Cristina Loomis - Bothell WA, US
International Classification:
C07K 16/18, C12N 15/63, C12N 1/19, A61K 39/395, A61K 49/00, A61K 51/00, C12Q 1/68, C12N 5/10, C12N 1/15, C12N 1/21, A61P 25/06, A61P 3/00, A61P 35/00, A61P 25/00, A61P 29/00, A61P 19/08, A61P 1/16, A61P 13/12, A61P 13/00, A61P 3/10, A61P 37/00, A61P 9/00, A61P 19/02, A61P 11/00, A61P 11/06, A61P 25/36, A61P 15/00, A61P 17/00, A61P 17/06, A61P 25/08, A61P 25/28, A61P 17/04, A61P 1/00, A61P 37/08, A61P 31/00, C12N 15/13
US Classification:
424 111, 5303891, 5303873, 5303913, 5303917, 536 2353, 4353201, 43525423, 4241721, 424 91, 424 96, 5303911, 4241331, 435 61, 435332, 43525411, 43525233, 4241581
Abstract:
The present invention is directed to antibodies and fragments thereof having binding specificity for CGRP. Another embodiment of this invention relates to the antibodies described herein, and binding fragments thereof, comprising the sequences of the V, Vand CDR polypeptides described herein, and the polynucleotides encoding them. The invention also contemplates conjugates of anti-CGRP antibodies and binding fragments thereof conjugated to one or more functional or detectable moieties. The invention also contemplates methods of making said anti-CGRP antibodies and binding fragments thereof. Embodiments of the invention also pertain to the use of anti-CGRP antibodies, and binding fragments thereof, for the diagnosis, assessment and treatment of diseases and disorders associated with CGRP.
Anti-Pcsk9 Antibodies And Use Thereof
US Patent:
2013030, Nov 14, 2013
Filed:
Mar 12, 2013
Appl. No.:
13/795674
Inventors:
Andrew Lawrence Feldhaus - Lynnwood WA, US
Leon F. Garcia-Martinez - Woodinville WA, US
Benjamin H. Dutzar - Seattle WA, US
Ethan Wayne Ojala - Snohomish WA, US
Brian Robert Kovacevich - Snohomish WA, US
Katie Olson - Kenmore WA, US
Pei Fan - Bothell WA, US
Jens Billgren - Seattle WA, US
Erica Ann Stewart - Shoreline WA, US
Corinne C. Akatsuka - Hilo HI, US
Patricia Dianne McNeill - Federal Way WA, US
Danielle Marie Mitchell - Seattle WA, US
Dan Scott Allison - Lake Forrest Park WA, US
John A. Latham - Seattle WA, US
Leon F. Garcia-Martinez - Woodinville WA, US
Benjamin H. Dutzar - Seattle WA, US
Ethan Wayne Ojala - Snohomish WA, US
Brian Robert Kovacevich - Snohomish WA, US
Katie Olson - Kenmore WA, US
Pei Fan - Bothell WA, US
Jens Billgren - Seattle WA, US
Erica Ann Stewart - Shoreline WA, US
Corinne C. Akatsuka - Hilo HI, US
Patricia Dianne McNeill - Federal Way WA, US
Danielle Marie Mitchell - Seattle WA, US
Dan Scott Allison - Lake Forrest Park WA, US
John A. Latham - Seattle WA, US
International Classification:
C07K 16/40, A61K 45/06, A61K 39/395
US Classification:
424450, 5303898, 5303917, 435188, 5303872, 4241581, 536 2353, 4353201, 435338, 4352523, 43525411, 4352542, 43525423, 43525422, 43525421, 4352543, 4352547, 4352546, 4352544, 435 696, 435 74, 5303913
Abstract:
The present invention is directed to antibodies and fragments thereof having binding specificity for PCSK9. Another embodiment of this invention relates to the antibodies described herein, and binding fragments thereof, comprising the sequences of the V, Vand CDR polypeptides described herein, and the polynucleotides encoding them. The invention also contemplates conjugates of anti-PCSK9 antibodies and binding fragments thereof conjugated to one or more functional or detectable moieties. The invention also contemplates methods of making said anti-PCSK9 antibodies and binding fragments thereof. Embodiments of the invention also pertain to the use of anti-PCSK9 antibodies, and binding fragments thereof, for the diagnosis, assessment and treatment of diseases and disorders associated with PCSK9.